Autonomic Failure
21
8
8
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.8%
1 terminated out of 21 trials
91.7%
+5.1% vs benchmark
0%
0 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (21)
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Mechanisms of Hypoglycemia Associated Autonomic Failure
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Automated Abdominal Binder for Orthostatic Hypotension
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
Treatment of Supine Hypertension in Autonomic Failure (CPAP)
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
CPAP for the Treatment of Supine Hypertension
Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System
Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease
Concentration and Attentional Deficits in POTS and Other Autonomic Neuropathies
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
Local Heat Stress in Autonomic Failure Patients With Supine Hypertension
Plasma Exchange for Autoimmune Autonomic Failure
Treatment of Orthostatic Hypotension in Autonomic Failure